Overview of A-H
Quick Facts
| Property | Description |
|---|---|
| Active ingredient | Doxylamine succinate (and Pyridoxine HCl in specialized forms) |
| Form | Oral tablet, extended-release tablet, liquid, capsule |
| Pharmacological class | First-generation histamine H1 receptor antagonist |
| Common use | Short-term sleep support, relief of allergy symptoms |
| Origin | Synthetic (Ethanolamine derivative) |
What Type of Medicine is A-H (Doxylamine)?
A-H is a medicinal product containing the active ingredient Doxylamine succinate, which is primarily classified as a first-generation histamine H1 receptor antagonist. Doxylamine is a synthetic compound that is readily available to consumers in many regions, often as an Over-the-Counter (OTC) product. Its function involves competing with histamine at receptor sites. Unlike newer antihistamines, Doxylamine is distinctively characterized by its ability to cross the blood-brain barrier efficiently, which leads to its prominent secondary classification as a powerful sedative/hypnotic agent. Its general purpose is thus dual: to address common allergic symptoms and to act as a sleep aid for individuals experiencing temporary difficulty falling asleep.
Composition and Physical Forms of Doxylamine
The pharmacological core of A-H is Doxylamine succinate, chosen for its stability and effectiveness upon oral administration. Doxylamine is widely distributed as a single-ingredient product, typically in the form of an oral tablet used primarily for its sedative property. Crucially, the compound is also manufactured as a fixed-dose combination product alongside Pyridoxine hydrochloride (a B-vitamin derivative). This specialized combination, which differs markedly from the single-ingredient formulation, is indicated for managing sickness associated with pregnancy. These products are available in various dosage forms, including immediate-release tablets, extended-release forms, and aqueous liquid solutions.
General Purpose and Core Action of A-H
The primary general purpose of A-H is to provide short-term support for achieving sleep and to relieve discomfort associated with allergic reactions. This is achieved through its principal physiological action, the antagonism of histamine at H1 receptor binding sites. The medication’s pronounced ability to enter the central nervous system induces a reliable sedative effect that promotes rest. Furthermore, Doxylamine exhibits a complementary anticholinergic effect that generally assists in managing discomfort by reducing secretions from common symptoms like watery eyes and runny nose.
